EXELIXIS, INC.

Biological Products, (No Diagnostic Substances)·ALAMEDA, CA·FY end 01/01·CIK 939767

Named Executive Officers

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Dr. Morrissey · CEO	—	—	—	—	—	$33.2M
Michael M. MorrisseyPh.D.	$1.3M	$30.5M	—	$1.4M	$11.0K	$33.2M
Amy C. PetersonM.D.	$614.5K	$8.4M	—	—	$2.1M	$11.1M
Christopher J. SennerExecutive Vice President	$822.8K	$9.3M	—	$470.8K	$11.0K	$10.6M
Dana T. AftabPh.D.	$659.1K	$9.5M	—	$397.3K	$11.0K	$10.5M
Jeffrey J. HessekielJ.D.	$672.4K	$8.3M	—	—	$11.0K	$9.0M
Research and Development	$577.9K	$4.8M	—	$294.1K	$11.0K	$5.7M
Brenda J. HeftiJ.D., Ph.D. Senior Vice President and General Counsel	$454.5K	$3.5M	—	$286.8K	$11.0K	$4.2M
Dr. Hefti	—	—	—	—	—	—
Dr. Aftab	—	—	—	—	—	—
Mr. Haley	—	—	—	—	—	—
Dr. Peterson	—	—	—	—	—	—
Mr. Senner	—	—	—	—	—	—
Patrick J. HaleyExecutive Vice President, Commercial	$621.3K	$8.1M	$327.3K	$11.0K	$9.0M	—
Mr. Hessekiel	—	—	—	—	—	—

Dr. Morrissey · FY 2025

TSR % vs. CEO comp actually paid · 5 fiscal years · Item 402(v) disclosure

TSR

CEO comp

FY20

+18%

$19M

FY21

+7%

$15M

FY22

-6%

$16M

FY23

+41%

$32M

FY24

+100%

$39M

CEO total compMedian employeePay ratio (right axis)